Today in News History

On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1920, The Soviet-Lithuanian Peace Treaty is signed, by which Soviet Russia recognizes the independence of Lithuania. In 1931, Nathan Söderblom, Swedish archbishop, Nobel Prize laureate (born 1866) passed away. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1958, J. D. Hayworth, American politician and radio host was born. In 1959, Tupou VI, King of Tonga was born. In 1986, JP Pietersen, South African rugby player was born. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 2000, Charles Merritt, Canadian colonel and politician, Victoria Cross recipient (born 1908) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Experimental DNA nasal vaccine shows promise against tuberculosis

Syrian Arab News Agency

Syrian Arab News Agency

·

July 5, 2026

·

lean left
Experimental DNA nasal vaccine shows promise against tuberculosis

Washington, July 5 (SANA) An experimental DNA-based nasal vaccine has shown promising results against tuberculosis (TB) in animal studies, raising hopes for a more effective treatment for one of the world’s deadliest infectious diseases. The vaccine, developed by researchers at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public []

Narrative Intelligence Brief

This article was published by Syrian Arab News Agency, a source frequently categorized with a lean left bias based in Syria. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Syrian Arab News Agency, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 33%

Center 33%

Right 33%


UrduPoint

lean right

· Jul 4, 2026

US scientists develop nose spray DNA vaccine for tuberculosis

US scientists develop nose spray DNA vaccine for tuberculosis

NPR Topics: Health

lean left

· Jun 27, 2026

If a Lyme disease vaccine gets approved, how would it go over? We asked hunters

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?

Arise News

center

· Jul 1, 2026

TETFund Tasks Scientists To Develop Nigeria’s First Lassa Fever Vaccine

TETFund urges researchers to accelerate efforts to produce an indigenous vaccine against Lassa fever.

Brisbane Times

center

· Jul 8, 2026

Australians scientists develop painless alternative to traditional vaccines

There is hope for a potentially painless alternative to vaccines, as Australian scientists help develop a dissolvable patch to substitute traditional injections.

Bloomberg

lean left

· Jul 4, 2026

Ebola Vaccine Trials Could Start This Year

As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)

TRT World

right

· Jun 26, 2026

A promising Bundibugyo Ebola vaccine was shelved 15 years ago

Scientists developed an experimental vaccine for the Bundibugyo strain of Ebola more than a decade ago, and early studies showed promising results. But with outbreaks rare and funding scarce, development stalled. Now, as Bundibugyo Ebola spreads again, researchers are racing to catch up.

Topics:

World · 3
Health · 1
Politics · 1
Business · 1

Related coverage for "Experimental DNA nasal vaccine shows promise against tuberculosis": UrduPoint — US scientists develop nose spray DNA vaccine for tuberculosis. NPR Topics: Health — If a Lyme disease vaccine gets approved, how would it go over? We asked hunters. Arise News — TETFund Tasks Scientists To Develop Nigeria’s First Lassa Fever Vaccine. Brisbane Times — Australians scientists develop painless alternative to traditional vaccines. Bloomberg — Ebola Vaccine Trials Could Start This Year. TRT World — A promising Bundibugyo Ebola vaccine was shelved 15 years ago